# FDA Inspection 1261247 - Ascent Pharmaceuticals Inc - February 03, 2025

Source: https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/c809c793-a2a4-4d29-b653-366bab81e064
Source feed: FDA_Inspections

> FDA Inspection 1261247 for Ascent Pharmaceuticals Inc on February 03, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261247
- Company Name: Ascent Pharmaceuticals Inc
- Inspection Date: 2025-02-03
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1229681 - 2024-08-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/ad54fbcb-6020-4316-b662-c5582cc31d0d)
- [FDA Inspection 1179615 - 2022-09-15](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/23ea7cb5-85bb-4ee6-96ce-1106d4aec03b)
- [FDA Inspection 1132410 - 2020-10-13](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/2cafc3cb-16db-4e60-997f-df0b11b87a48)
- [FDA Inspection 1074882 - 2018-11-07](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/b6df4373-5d5c-4445-88c2-715ab5b7de63)
- [FDA Inspection 1067030 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/9cf4d629-afe2-4c60-b178-4dbf4b73f2f4)

Company: https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d